³í¹®½ÇÀû

Áö¿ø°úÁ¦º° :
¿¬µµº° :
¸ðµÎº¸±â
Eugenol inhibit 7,12-dimethylbenz[a]anthracene-induced genotoxicity in MCF-7 cells: Bifunctional effects on CYP1 and NAD(P)H:quinone oxidoreductase.()
FEBS Lett. 2007 Feb 20;581(4):749-56 [LINK]
2007-International
A new CYP3A5 variant, CYP3A5*11, is shown to be defective in nifedipine metabolism in a recombinant cDNA expression system.()
Drug Metab Dispos. 2007 Jan;35(1):67-71. [LINK]
2006-International
Possible interethnic differences in quinidine-induced QT prolongation between healthy Caucasian and Korean subjects.()
Br J Clin Pharmacol. 2007 Feb;63(2):206-15. [LINK]
2006-International
Effect of CYP3A5*3 genotype on the pharmacokinetics and pharmacodynamics of amlodipine in healthy Korean subjects.()
Clin Pharmacol Ther. 2006 Dec;80(6):646-56. [LINK]
2006-International
Protein-kinase-C-mediated {beta}-catenin phosphorylation negatively regulates the Wnt/{beta}-catenin pathway.(PRCDM)
J Cell Sci. 2006 Nov 15;119(Pt 22):4702-9. [LINK]
2006-International
Inhibitory effect of anethole on T-lymphocyte proliferation and interleukin-2 production through down-regulation of the NF-AT and AP-1.()
Toxicol In Vitro. 2006 Oct;20(7):1098-105. [LINK]
2006-International
Characterization of ebastine, hydroxyebastine, and carebastine metabolism by human liver microsomes and expressed cytochrome P450 enzymes: major roles for CYP2J2 and CYP3A.(NRL)
Drug Metab Dispos. 2006 Nov;34(11):1793-7. [LINK]
2006-International
The disposition of reduced haloperidol and HPP+ Metabolites of haloperidol, is not influenced by P-Glycoprotein()
Kor J Clin Pharmacol Ther. 14(1): 42-50 [LINK ]
2006-Domestic
CYP2C9 Pharmacogenomics: Recent Update and Clinical Relevance.()
Kor J Clin Pharmacol Ther. 14(1): 3-16 [LINK ]
2006-Domestic
Characterization of Pyribenzoxim Metabolizing Enzymes in Rat Liver(PRCDM)
한국독성학회, 22(1), 1-8 [LINK ]
2006-Domestic